Patent · US Active

Pyrrolotriazine compounds as TAM inhibitors

US10844069B2 · kind B2 · utility

9Cited by
7References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 4, 2019
Grant dateNov 24, 2020
Priority date—
Expiry dateSep 4, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.